Molecular complexity and fragment-based drug discovery: ten years on
Authors:
- 1 August 2011
- journal article
- review article
- Published by Elsevier in Current Opinion in Chemical Biology
- Vol. 15 (4) , 489-496
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Fragment-Based Drug Design: How Big Is Too Big?Journal of Medicinal Chemistry, 2006
- Fragment screening: an introductionMolecular BioSystems, 2006
- Pursuing the leadlikeness concept in pharmaceutical researchCurrent Opinion in Chemical Biology, 2004
- Ligand efficiency: a useful metric for lead selectionDrug Discovery Today, 2004
- A ‘Rule of Three’ for fragment-based lead discovery?Drug Discovery Today, 2003
- The Design of Leadlike Combinatorial LibrariesAngewandte Chemie International Edition, 1999
- The maximal affinity of ligandsProceedings of the National Academy of Sciences, 1999
- The art and practice of structure-based drug design: A molecular modeling perspectiveMedicinal Research Reviews, 1996
- New hydrogen-bond potentials for use in determining energetically favorable binding sites on molecules of known structureJournal of Medicinal Chemistry, 1989
- Functional group contributions to drug-receptor interactionsJournal of Medicinal Chemistry, 1984